Get the Stockscreener App
1.15
2.54%
-0.03
Nuwellis Inc stock is traded at $1.15, with a volume of 98,054.
It is down -2.54% in the last 24 hours and down -11.54% over the past month.
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.
See More
Previous Close:
$1.18
Open:
$1.2
24h Volume:
98,054
Relative Volume:
0.20
Market Cap:
$5.03M
Revenue:
$8.97M
Net Income/Loss:
$-15.21M
P/E Ratio:
-0.00987
EPS:
-116.51
Net Cash Flow:
$-10.84M
1W Performance:
-11.20%
1M Performance:
-11.54%
6M Performance:
-15.44%
1Y Performance:
-92.54%
1-Day Range:
$1.102
$1.21
1-Week Range:
$1.102
$1.34
52-Week Range:
$0.9237
$16.62
Nuwellis Inc Stock (NUWE) Company Profile
Name
Nuwellis Inc
Sector
Industry
Phone
952-345-4200
Address
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
1.15 | 5.03M | 8.97M | -15.21M | -10.84M | -116.51 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | ROTH MKM | Buy |
Nuwellis Inc Stock (NUWE) Latest News
Nuwellis, Inc. Earnings Call: Mixed Results with Promising Prospects - TipRanks
Nuwellis, Inc. Reports 2024 Financial Results and Strategic Progress - TipRanks
Earnings call transcript: Nuwellis Q4 2024 sees improved margins, stock dips - Investing.com Canada
Nuwellis price target lowered to $13 from $16 at Roth MKM - TipRanks
Earnings call transcript: Nuwellis Q4 2024 sees improved margins, stock dips By Investing.com - Investing.com South Africa
Nuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates (Revised) - Yahoo Finance
Nuwellis Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Medical device maker Nuwellis posts fourth-quarter sales of $2.3 mln -March 11, 2025 at 09:08 am EDT - Marketscreener.com
Nuwellis, Inc. (NUWE) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Nuwellis reports Q4 EPS (44c) vs ($54.48) last year - TipRanks
Nuwellis Earnings Show Major Medicare Win: 4X Payment Boost Coming as Critical Care Surges - StockTitan
Nuwellis (NUWE) Projected to Post Earnings on Tuesday - Defense World
Nuwellis, Inc. to Host Earnings Call - ACCESS Newswire
Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO - The Manila Times
Nuwellis Appoints John Erb as Interim CEO - MSN
Nuwellis announces CEO retirement - MSN
Nuwellis Announces Retirement Of Nestor Jaramillo, Jr. As President And CEO -February 24, 2025 at 05:07 pm EST - Marketscreener.com
Nuwellis announces leadership transition with interim CEO By Investing.com - Investing.com Canada
Nuwellis announces leadership transition with interim CEO - Investing.com India
Can Nuwellis' Former CEO Steady the Ship? Key Details of Leadership Shuffle - StockTitan
JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis - The Manila Times
Nuwellis, Inc. Reports 60% Reduction in Heart Failure Events with Aquadex® SmartFlow Ultrafiltration Therapy in Updated AVOID-HF Study Analysis - Nasdaq
Revolutionary Heart Failure Treatment Cuts Patient Events by 60%New Study Reveals Why It Matters - StockTitan
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025 - The Manila Times
Nuwellis, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025 - Nasdaq
Nuwellis Financial Results: Strategic Update and 2024 Performance Review Coming Next Month - StockTitan
Short Interest in Nuwellis, Inc. (NASDAQ:NUWE) Rises By 67.8% - Defense World
Nuwellis (NASDAQ:NUWE) Stock Price Up 2.4% – Here’s What Happened - Defense World
Nuwellis Inc (NUWE) produces promising results - US Post News
Market Highlights: Nuwellis Inc (NUWE) Ends on a Low Note at 1.21 - The Dwinnex
Update on Alert: Extracorporeal Blood Circuit Issue from Nuwellis - FDA.gov
Xcorporeal (OTCMKTS:XCRP) versus Nuwellis (NASDAQ:NUWE) Critical Review - Defense World
Roth Capital Has Optimistic View of Nuwellis FY2024 Earnings - Defense World
Equities Analysts Issue Forecasts for Nuwellis Q1 Earnings - Defense World
Nuwellis Stock Spikes After Reimbursement Hike: Retail’s Upbeat - MSN
Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow® Therapy - The Manila Times
Nuwellis Expands Pediatric Reach: Aquadex SmartFlow System Adopted by Major Utah Hospital - StockTitan
FDA issues early alert against Nuwellis’ extracorporeal blood circuits - Medical Buyer
FDA And Nuwellis Address Potentially High-Risk Issue With Blood Circuit Device - AOL
FDA issues “high-risk” safety alert to Nuwellis blood circuit sets - Yahoo Finance
FDA says aware Nuwellis recalling certain blood circuit lots - TipRanks
CHF Solutions, Inc. Receives Registration from FDA Thailand to Allow the Sale of Aquadex Flex Flow® in Thailand - Marketscreener.com
Nuwellis regains Nasdaq compliance with bid and equity rules - Investing.com
Nuwellis Regains Compliance with Nasdaq Listing Requirements - The Manila Times
Nuwellis Secures Nasdaq Listing Future After Meeting Critical Compliance Requirements - StockTitan
Nuwellis announces voluntary recall of blood circuit lots - Investing.com
Earnings call: Nuwellis reports mixed Q3 results amid segment shifts By Investing.com - Investing.com Nigeria
Nuwellis (ASX:SHC) Profitability Rank : 1 (As of Sep. 2024) - GuruFocus.com
Nuwellis (ASX:SHC) 3-Year FCF Growth Rate : 73.20% (As of Sep. 2024) - GuruFocus.com
Nuwellis, Inc. (NUWE) Q3 Earnings Surpass Estimates - MSN
Nuwellis Inc Stock (NUWE) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):